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Fragile X Syndrome (FXS) is the most common form of inherited cognitive disability.
However, functional deficiencies in FX neurons have been described so far almost
exclusively in animal models. In a recent study we found several functional deficits in
FX neurons differentiated in-vitro from human embryonic stem cells (hESCs), including
their inability to fire repetitive action potentials, and their lack of synaptic activity. Here, we
investigated the responses of such neurons to pulse application of the neurotransmitter
GABA. We found two distinct types of responses to GABA and sensitivity to the GABA-A
receptor antagonist bicuculline; type 1 (mature) characterized by non-desensitized
responses to GABA as well as a high sensitivity to bicuculline, and type 2 (immature)
which are desensitized to GABA and insensitive to bicuculline. Type 1 responses
were age-dependent and dominant in mature WT neurons. In contrast, FX neurons
expressed primarily type 2 phenotype. Expression analysis of GABA-A receptor subunits
demonstrated that this bias in human FX neurons was associated with a significant
alteration in the expression pattern of the GABA-A receptor subunits α2 and β2. Our
results indicate that FMRP may play a role in the development of the GABAergic synapse
during neurogenesis. This is the first demonstration of the lack of a mature response to
GABA in human FX neurons and may explain the inappropriate synaptic functions in FXS.
Keywords: Fragile X syndrome, GABA, neural development, human embryonic stem cells, in-vitro neural
differentiation
INTRODUCTION
Fragile X syndrome (FXS) is the most common form of inherited intellectual disability
(Penagarikano et al., 2007; Bagni and Oostra, 2013). Individuals with FXS show cognitive
disabilities, as well as high-comorbidity with autism and epilepsy. It is caused by developmentally
regulated silencing of the FMR1 gene, and absence of its encoded protein, FMRP (Willemsen et al.,
2002). Loss of FMRP impairs neurogenesis of adult neural stem cells in mice (Luo et al., 2010;
Guo et al., 2011) as well as embryonic neurogenesis of human pluripotent stem cells and neural
precursor cells (Eiges et al., 2007; Adusei et al., 2010; Sheridan et al., 2011; Telias et al., 2013, 2015b).
In FX neurons obtained from fmr1−/− mice, the absence of the FMRP protein has been
linked to an aberrant response to either the glutamate or the gamma-aminobutyric acid (GABA)
neurotransmitter (Bear et al., 2004; Braat and Kooy, 2015). Several studies in fmr1−/− mice have
demonstrated a link between the GABAergic inhibitory system and the impaired neuronal activity
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observed in FXS (Braat and Kooy, 2015), in which abnormal
expression of GABAergic proteins in different brain areas and
during different developmental stages has been shown (Adusei
et al., 2010; Kratovac and Corbin, 2013). During development,
neurons first respond to GABA with excitation and later switch
to inhibition (Ben-Ari, 2015). It was later reported that such
developmental switch is delayed in fmr1−/− mice (He et al.,
2014). However, this hypothesis has not been tested in human
FX neurons, mainly due to the lack of suitable research models.
Therefore, analysis of the functional and molecular expression of
the GABArgic synapse in-vitro in FX human neurons can shed
new light on the involvement of inhibitory transmission in FXS.
We were able to derive FX human embryonic stem cells
(hESCs) carrying the naturally occurring full mutation (>200
CGG repeats) at the FMR1 locus, and demonstrated that
in-vitro neural differentiation effectively produces neurons that
gradually lose FMRP, and consequently demonstrate impaired
neurogenesis (Telias et al., 2013). Recently, we have shown
that this gradual downregulation of FMRP during neurogenesis
until its complete absence in mature neurons leads to impaired
electrophysiological properties, including lack of repetitive action
potential firing, reduced neurotransmitter release and poor
synaptogenesis (Telias et al., 2015a). In the present study we
analyzed the functional response of these FX human neurons to
GABA. Our results show that hESC neurons produce two types
of responses to GABA, a mature (type 1) and an immature (type
2) response: in wild-type (WT) neurons, the immature responses
are gradually replaced by the mature form, but in FX cells, type
2 responses are persistent. In addition, human FX neurons have
increased RNA levels of GABA-Aα2 and reduced RNA levels
of GABA-Aβ2. Taken together our results indicate that lack of
FMRP may affect the composition of the GABA-A receptors and
prevents their maturation.
MATERIALS AND METHODS
Human Embryonic Stem Cells and In-vitro
Neural Differentiation
The use of spare IVF-derived embryos diagnosed by Pre-
implantation Genetic Diagnosis (PGD) for the derivation of
hESCs was approved by the Israeli National Ethics Committee
(7/04-043). Three Fragile X human embryonic stem cell
(hESC) lines with >200 CGG repeats in the FMR1 gene were
studied: HEFX1 (male) and Lis_FX6 (male), derived at Tel-
Aviv Sourasky Medical Center and SZFX6 (male), derived in
Shaare Tzedek Medical Center. These three lines were entitled
here systematically: FX1, FX2, and FX3, and were all fully
characterized previously (Eiges et al., 2007; Telias et al., 2013).
The hESC line HUES-13 (male; kindly provided by the Melton
Lab, Harvard University), was previously shown by us to include
<30 CGG repeats in the FMR1 gene (Telias et al., 2013)
and was used here as WT. hESCs were cultured on feeder
layers of mitomycin C (Sigma)-inactivated mouse embryonic
fibroblasts (MEF) in hES-medium supplemented with bFGF
(R&D), as we previously described (Telias et al., 2013, 2015a).
Before induction of in-vitro neural differentiation, hESCs were
cultured on Matrigel (BD)-coated wells for two passages. The
dual SMAD inhibition protocol was applied as we previously
described (Telias et al., 2014, 2015a). Briefly, neural induction
was achieved by gradually changing the medium from hES to
N2 while adding dorsomorphin and SB431542 for 10 days;
for neuronal induction the medium was changed to N2/B27
supplemented with BDNF, GDNF, ascorbic acid, dbcAMP and
DAPT for 10 additional days. At day 20 cells were dissociated
using Accutase (Life Tech.) and seeded on 13mm glass coverslips
pre-coated with 50µg/ml Poly-D-Lysine and 20µg/ml Laminin
(Sigma) at a seeding density of ∼1.0 × 105 cells/cm2. From
day 20, neurons were continuously grown in N2/B27 medium
supplemented with 20 ng/ml BDNF, GDNF, and NT3, unless
otherwise specified. Concentrations of reagents and growth
factors used were as follows: 5µM dorsomorphin (Stemgent),
10µM SB431542 (Stemgent), 20 ng/ml BDNF (PeproTech),
20 ng/ml GDNF (PeproTech), 0.2mM ascorbic acid (Sigma),
0.5mM dbcAMP (Sigma), 10µM DAPT (Tocris), 20 ng/ml NT3
(PeproTech). N2 medium was composed of DMEM:F12 (Life
Tech.), supplemented with 1% N2 (Life Tech.), 1% non-essential
amino acids (BioInd.), 1% Glutamax (Life Tech.), and 100µg/ml
Primocin (InvivoGen). N2/B27 Medium was a 1:1 mixture of
N2 and B27 media. B27 medium was composed of Neurobasal
(Life Tech.), supplemented with 1% B27 (Life Tech.), 1% non-
essential amino acids (BioInd.), 1% Glutamax (Life Tech.), and
100µg/ml Primocin (InvivoGen). Differentiation was carried out
three times for each hESC line, cells were analyzed between days
40 and 160.
Electrophysiology and Pharmacology
Recordings were conducted as previously described (Telias et al.,
2013, 2014, 2015a). In brief, neurons differentiated on glass
coverslips were transferred to a recording chamber in standard
recording medium, containing (in mM):10 HEPES, 4 KCl, 2
CaCl2, 1 MgCl2, 139 NaCl, 10 D-glucose (340 mOsm, pH 7.4).
Cells were patch-clamped with pipettes containing (in mM) 136
K-gluconate, 10 KCl, 5 NaCl,10 HEPES, 0.1 EGTA, 0.3 Na-GTP,
1 Mg-ATP, and 5 phosphocreatine, pH 7.2 (pipette tip resistance
was 5–8 M). Membrane potential was held at −60mV. GABA
(2mM in the pressure pipette, tip diameter 2–4µm) was applied
within 10µm from the recorded neuron for a duration of
50ms. Signals were amplified with a Multiclamp700B amplifier
and recorded with Clampex 9.2 software (Axon Instruments).
Bicuculline (Sigma) was applied at a concentration of 20µM into
the recording bath.
Quantitative Real Time PCR
Relative transcription levels were analyzed using quantitative
Real Time PCR (qRT-PCR) on cDNA reversed transcribed
from RNA samples. RNA extracted from cells (RNAeasy Mini
Kit–Qiagen), was stored at −80◦C with RNAse Inhibitor
(Roche) and DNAseI (Roche). RNA (100 ng) was reversed
transcribed with Super Script III RT-PCR kit (Invitrogen).
Quantitative Real Time PCR (qRT-PCR) was performed using
SYBR Green (ABgene). Cycling and analysis were performed
using Rotor Gene 6000 Series (Corbett) and its complementary
analysis software. The house keeping gene GAPDH was used
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as a control for 11Ct analysis of results. All qRT-PCR
assays included Non-Template Control (NTC), and adult
human-FXS white blood cells. Oligo DNAs (custom made
primers) were purchased from Sigma, and their sequences
are as follows: GAPDH, Fwd: AGCCACATCGCTCAGACA
CC, Rev: ATACGACCAAATCCGTTGACTC; Gephyrin, Fwd:
ATGATCCTTACTAACCACGACCA, Rev: AGATTTATCCCA
CTGCGGTCTT; GABA-Aα1, Fwd: GGAAGAAGCTATGGA
CAGCCG, Rev: AATCCTGGTCTCAGGCGATTG; GABA-Aα2,
Fwd: GCCAATCAATCGGAAAGGAGAC, Rev: TTCCCATCC
CAAGTCCATCCTC;GABA-Aβ2, Fwd: TGCCTGATACCTATT
TCCTGAACG, Rev: GATTCCTAATGCCACCCTTGC; GABA-
Aγ 2S, Fwd: TGCACACTCATTGTCGTCCTATCCTGG, Rev:
TTAAACAGGCAGAAGGCAGTGGGG; GABA-Aδ, Fwd: AGG
ACATCGTCTACTACTGGTCGGAGAG, Rev: TCGGCGTTG
AAATGAGCAAAGG.
Immunofluorescence
Immunostaining was performed as described previously (Telias
et al., 2013, 2015b). Briefly, cells were fixed for 15min at room
temperature (RT) using Cytofix (BD Biosciences) and washed
with PBS. Primary antibodies were incubated overnight at 4◦C,
in a PBS solution containing 2.5% BSA and 0.1% Triton. Staining
with secondary antibody was performed for 1 h at RT in the
dark. Primary antibodies, mouse anti-human TUJ1 (Millipore),
and rabbit anti-human GAD 65 (Santa Cruz), were detected
using sheep anti-mouse Cy2-conjugated or goat anti-rabbit Cy3-
conjugated secondary antibodies (Jackson Laboratories). Nuclei
were stained with DAPI (Sigma-Aldrich). Images were taken
using a Zeiss LSM 700 confocal microscope.
Data Analysis
Data from patch clamp recordings were subjected to a 500-Hz
low-pass filter and analyzed using Clampfit-9 and SigmaPlot.
Statistical analysis was performed using SigmaPlot and online
GraphPad QuickCalcs (http://www.graphpad.com/quickcalcs).
Difference level of<0.05 was considered significant.
RESULTS
Responses to GABA in Neurons
Differentiated In-vitro from Human
Embryonic Stem Cells
The responses of FX and WT neurons to GABA were examined
between days 40 and 160 of in-vitro neural differentiation, carried
out three times in three FX-hESC lines (designated FX1, FX2,
and FX3) and one WT-hESC line (see Section Materials and
Methods and Figure 1A). As we previously reported, both WT-
and FX-derived neurons express the neuronal proteins NeuN,
CaMK-II, TUJ1, and MAP2, but FX neurons do not express
FMR1 or FMRP (Telias et al., 2015a). Here we show that already
at day 40 of differentiation, both WT and FX neurons, express
FIGURE 1 | (A) Outline of the time-course of neuronal differentiation and the time-points at which electrophysiological recordings were carried out in WT (blue) and FX
(red) human embryonic stem cells-derived neurons. (B) Immunofluorescence images for cellular localization of TUJ1 (green, left), GAD65 (red, middle) and their overlay
(yellow, right); in WT (top row), and FX (bottom row) 40-days old neurons. Scale is 50µm.
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co-localized GAD65 (glutamic acid decarboxylase 65) and TUJ1,
indicating that these neurons have the enzymatic machinery
necessary for producing and secreting GABA (Figure 1B). From
these immunostaining assays we could estimate that >∼90% of
TUJ1-positive cells were also positively stained for GAD65. We
have already shown that critical differences in firing patterns and
synaptic activity exist between FX and WT neurons (including
impaired action potential firing and reduced spontaneous
synaptic activity) during the same time frame of differentiation
considered in the present study (Telias et al., 2015a). In the
present study we analyzed the electrophysiological responses
of WT and FX neurons to topical application of GABA. At
several time-points during differentiation (Figure 1A—blue and
red arrows), we carried-out patch clamp recordings on WT
and FX-hESC derived neurons. Voltage-clamped cells, held at
−60mV were exposed to a 50-ms, 2mM GABA applied through
a pressure pipette. Two distinct responses to GABA were found
in both WT and FX neurons, tentatively designated herein as
“type 1” and “type 2.” A total of 30 WT neurons were recorded
as compared to 35 FX neurons (FX1 n = 11, FX2 n = 9, FX3
n = 15), in three differentiation experiments (Figures 2A,B).
Type 1 responses were characterized as persistent and non-
desensitized inward currents to successive pulse application of
GABA. In contrast, type 2 responses showed time-dependent
desensitization of reactivity to GABA, such that a consecutive
GABA pulse applied ∼1 s later resulted in no response, whereas
30 s later a∼80% reduction in the peak amplitude of the recorded
current was still evident, and a full recovery was found more
than 120 s after the first response (Figure 2A). However, both
type 1 and 2 responses showed similar reversal potentials (Er),
between −30 and −20mV at an equivalent age (Figure 2B). In
addition, the two types differed in their sensitivity to the GABA-
A receptor antagonist bicuculline (BIC, at 20µM; Figure 2C). In
type 1 responses, BIC abolished GABA induced currents in all
cells tested (WT n = 6, FX n = 1), while type 2 responses were
insensitive to BIC (WT n = 5, FX n = 8). It is important to note
that hyperpolarization of cells to −100mV speeded up recovery
from desensitization by∼50% in both WT and FX neurons (WT
n = 3, FX n = 4), and that none of the cells analyzed, WT or
FX, responded to pressure application of the GABA-B agonist
baclofen (10–20µM; WT n = 7, FX n = 6), indicating that the
responses are of GABA-A type.
Age Distribution of Type1 and Type2 in WT
and FX
Next, we analyzed the frequency distribution of type 1 vs. type
2 responses, in FX and WT neurons. Our results show that
37% of WT neurons (n = 11 of 30) were classified as having
type 1 responses, while 63% (n = 19 of 30) were classified as
type 2 (Figure 3A). In contrast, in FX neurons, only 9% (n =
3 of 35, all 3 from FX3 line only) were classified as type 1,
while 91% (n = 32 of 35) were of type 2. This bias of FX
neurons toward type 2 responses was statistically significant (p <
0.01). Furthermore, within type 2 responses, time-dependent
re-sensitization to GABA was significantly decreased in FX
neurons as compared to WT (Figure 3B), suggesting that FX
FIGURE 2 | Time-dependent responses of WT neurons to GABA.
(A) Representative traces of voltage-clamp recordings for time-dependent
responses to GABA demonstrating “type 1” (top) and “type 2” (bottom)
patterns. Cells were held at -60mV and 2mM GABA was applied by pressure
from an adjacent pipette. Recordings were taken for the first puff and following
consecutive delays of 30, 60, and 120 s. (B) Left panel, I-V curve for type 1
(circles) and type 2 (diamonds) GABA responses in single neurons. Right
panel, representative traces corresponding to the same neuron shown on the
left. Traces are sown for recordings at −60mV (black), −20mV (red), and
+40mV (green). (C) Representative traces of voltage-clamp recordings
showing sensitivity to 20µM bicuculline (BIC) in type 1 (WT n = 6, FX n = 1)
and lack of sensitivity to BIC in type 2 (WT n = 5, FX n = 8) responses to
GABA.
neurons have a higher tendency to a type 2-like response, with
increased desensitization in reaction to GABA and reduced
capability for re-sensitization. More importantly, the distribution
of both types of response was age-dependent in WT but not in
FX neurons (Figure 3C). Type 1-WT neurons were older, with
an in-vitro age ranging from 86 to 153 days, while type 2-WT
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FIGURE 3 | GABA responses in WT and FX neurons. (A) Total
incidence of type 1 and type 2 responses to GABA in WT (blue) and FX
(red) neurons. Values are the percent of cells in each category out of the
total number of cells examined. WT n = 30, FX n = 35 (FX1 n = 11, FX2
n = 9, FX3 n = 15). **p < 0.01, Chi-square test. (B) Quantification of
time-dependent re-sensitization in type 2 responses, in WT (blue) and FX
(red) neurons. Values are presented as percent of the peak current
obtained with the first GABA pulse (before desensitization). WT n = 30, FX
n = 35 (FX1 n = 11, FX2 n = 9, FX3 n = 15). Values are mean ± SEM.
*p < 0.05, t-test. (C) Box plot showing distribution of type 1 and type 2
responses in relation to neuronal in-vitro age following differentiation
induction, in WT (blue) and FX (red) neurons. WT n = 30, FX n = 35 (FX1
n = 11, FX2 n = 9, FX3 n = 15). *p < 0.05, **p < 0.01, Chi-square test. See
also Table 1 for details.
neurons were younger, with an in-vitro age ranging from 48 to
105 days (Table 1). This difference in age distribution between
type 1 and type 2 response in WT was statistically significant
(p < 0.05). In contrast, no age-dependency was found in FX
neurons. Only three cells were classified as type 1-FX, which were
all 105 days old and derived from line FX3 only. In contrast,
type 2-FX neurons showed an age distribution ranging from
day 40 to 138, which was significantly different from type 1-
WT, but not from type 2-WT or type 1-FX (Table 1). Therefore,
we conclude that type 2 response to GABA corresponds to an
immature neuronal phenotype, which develops into the mature
type 1 response. The strongly-biased distribution of FX neurons
toward type 2 suggests that FMR1 downregulation induced a
significant delay in the transition from an immature to a mature
neuronal phenotype, highlighting the important role played by
FMRP in human embryonic neuro-development in general, and
in the process of “GABA maturation” in particular. In our
recently published study on the electrophysiological deficiencies
of human FX neurons derived from hESCs (Telias et al., 2015a),
we showed that lack of spontaneous synaptic activity in FX cells
was rescued by co-culture with rat hippocampal neurons (Figure
S1A). However, co-culture did not reverse the type 2 response
to GABA in FX neurons (Figure S1B), further emphasizing the
idea that FMRP may exert a direct effect on GABA-A receptor
composition.
Expression of GABA-A Receptor Subunits
in WT and FX Neurons
In order to elucidate the molecular mechanism responsible for
the biased tendency of FX neurons toward type 2 responses,
we analyzed the expression of Gephyrin (which is specifically
expressed in GABAergic neurons) and several subunits of the
GABA-A receptor. RNA was extracted fromWT and FX neurons
at 120–130 days of differentiation, when most WT neurons
respond to GABA as type 1, but FX neurons are characterized as
type 2 (Figure 3C). We found that WT and FX neurons express
similar levels of Gephyrin and do not express GABA-Aα1 subunit
(data not shown). In contrast, FX neurons expressed significantly
higher levels of GABA-Aα2 subunit (WT = 100 ± 22.5%; FX
= 139.6 ± 9.8%; p < 0.05), and significantly lower levels of
GABA-Aβ2 subunit (WT = 100 ± 10%; FX = 17.7 ± 1.8%;
p < 0.01; Figure 4). Non-significant differences in expression
were found in GABA-Aγ 2S (WT = 100 ± 9.3%; FX = 75.3 ±
15.8%; p > 0.05), and in GABA-Aδ subunit (WT= 100± 11.5%;
FX = 107.1 ± 10.8%; p > 0.05). These results suggest that the
significant increase in the mRNA expression of α2 subunit and
the robust reduction in the mRNA expression of β2 subunit
in FX neurons could be responsible for the persistence of the
immature type-2 response in FX lines, and hint to a possible
developmentally regulatory role for FMRP in the expression of
specific GABA-A subunits.
An increase in α2 expression has been linked to slower
decay time in GABA-induced currents both in-vivo and in-
vitro (Okada et al., 2000; Dixon et al., 2014). Therefore, we
analyzed the value of tau in GABA responses in WT and FX
neurons (Figure 5A). Our analysis shows a statistically significant
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TABLE 1 | Full data for age distribution.
WT FX
Type 1 Type 2 Type 1 Type 2
No. of cells Age (days) No. of cells Age (days) No. of cells Age (days) No. of cells Age (days)
1 86 1 48 1 105 1 40
2 98 2 48 2 105 2 40
3 108 3 48 3 105 3 44
4 108 4 56 4 44
5 115 5 77 5 44
6 115 6 77 6 48
7 118 7 86 7 49
8 118 8 86 8 49
9 118 9 86 9 56
10 125 10 86 10 56
11 153 11 94 11 77
12 94 12 86
13 94 13 94
14 95 14 94
15 98 15 94
16 98 16 95
17 105 17 95
18 105 18 95
19 108 19 108
20 108
21 108
22 110
23 110
24 118
25 118
26 118
27 118
28 122
29 122
30 138
31 138
32 138
Mean 114.73 Mean 83.63 Mean 105 Mean 89.81
Sem 5.04 Sem 4.54 Sem 0 Sem 5.76
n 11 n 19 n 3 n 32
Full data corresponding to Figure 3C.The results for two-tailed p-values obtained from unpaired t-tests are as follows: WT, Type 1 vs. Type 2: 0.000152; FX, Type 1 vs. Type 2: 0.432;
Type 1, WT vs. FX: 0.347; Type 2, WT vs. FX: 0.459; Type 1-WT vs. Type 2-FX: 0.0203; Type 2-WT vs. Type 1-FX: 0.082. There was no statistically significant difference (p > 0.05) in
the age range of WT neurons ([48–153], n = 30) as compared to the age range of FX neurons ([40–138], n = 35).
increase in tau (i.e., slower mono-exponential decay) in FX
neurons displaying type 2 responses as compared to type 1
responses in WT and FX (both p < 0.01; Figure 5B). Tau
had a non-significant tendency to increase in type 2 responses
in WT neurons as compared to type 1-WT (p = 0.12) or
as compared to type 1-FX (p = 0.06), and to decrease as
compared to type 2-FX (p = 0.07). These results suggest that
an increase in α2 mRNA in FX cells could be responsible for the
immature response to GABA observed in the vast majority of FX
neurons.
DISCUSSION
In this study we examined the effect of the FMR1 mutation on
the functional and molecular aspects of the GABAergic system
in human neurons. We have shown that WT neurons obtained
by in-vitro neural differentiation of hESCs undergo an age-
dependent phase in which they exhibit a non-classical response to
GABA, characterized by time-dependent desensitization and lack
of sensitivity to GABA-A antagonist, bicuculline. We show that,
while this immature response is transient in WT neurons, it is
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FIGURE 4 | Expression of GABA-A receptor subunits in WT and FX
neurons. Quantitative Real Time PCR analysis of relative transcript levels for
the GABA-A receptor subunits: α2, β2, γ2S, and δ. Analysis was conducted
on RNA isolated from age 120 to 130 days WT (blue) neurons in 2 different
experiments, and from all three FX lines (red) in one experiment for each line; in
triplicates. Values were normalized to GAPDH (11Ct) and are shown as
mean ± SEM (% of control). *p < 0.05; **p < 0.01; t-test.
persistent across FX lines and throughout development. In order
to unveil the molecular mechanism behind this phenomenon, we
analyzed the transcription of specific GABA-A receptor subunits
and found an increase in the mRNA expression of the α2 subunit
and a robust reduction in the mRNA expression of the β2
subunit. These changes in the expression of GABA-A receptor
subunits might be associated with an increase in GABA-response
decay time. Our results suggest a role for FMRP in regulating the
maturation of GABAergic neurotransmission, characterized here
for the first time in human neurons.
Abnormal GABAergic Transmission
Associated with Fragile X
Neurodevelopment
It has been previously established that GABA-A receptors are
under-expressed in the hippocampus and cortex of fmr1−/−
mice (D’Hulst and Kooy, 2009; Braat and Kooy, 2015). Most
FIGURE 5 | Analysis of GABA response decay in WT and FX neurons.
(A) Representative traces of GABA responses and the exponential curve fit
used to calculate the value of the decay. A trace from a type 1 response in WT
is shown in blue and a trace from a type 2 response in FX is shown in red. Fit
curves are shown in black. (B) Measurement of the decay (Tau) in WT and FX
neurons, for type 1 and type 2 responses. Values are shown as mean ± SEM.
*p < 0.01, ANOVA.
importantly, it has been demonstrated that FMRP directly binds
mRNA of several GABA-A receptor subunits (Braat et al.,
2015). GABAergic transmission plays a crucial role during
neurodevelopment, in which it switches from excitatory to
inhibitory action due to changes in the intracellular chloride
concentration, affecting the development of neurons at various
levels, including their proliferation, migration, and dendritic
arborization (Ben-Ari et al., 2012). It has been recently reported
that in fmr1−/− mice, this developmental switch from excitation
to inhibition is delayed (He et al., 2014). Indeed, lack of
FMRP in developing cortical neurons increases the expression of
the Na+-K+-Cl− co-transporter, delaying the hyperpolarization
of Cl− reversal potential. In this study, we have uncovered
two distinct types of responses to GABA in human neurons:
while some of the neurons showed the expected response to
GABA (including consecutive responses to repeated exposures,
which were abolished by bicuculline), other neurons responded
with an atypical time-dependent desensitization to consecutive
GABA applications and complete insensitivity to bicuculline.
More importantly, we have shown the relevance of this specific
response in the context of human neurogenesis and FXS:
while this atypical response eventually disappears with age in
control neurons, it persists in FX neurons. These results suggest
a new mechanism for the developmental delays and cellular
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abnormalities observed during neurodevelopment of FX-hESCS,
concomitant with gradual downregulation of FMR1.
Desensitization of GABA-A receptors has already been
described in cultured hippocampal rodent neurons (Segal,
1993; Jones and Westbrook, 1995). Most importantly, such
desensitization was associated with younger age (1–7 days-
old) and disappeared with more advanced age (21–28 days-
old; Segal, 1993). Expression assays in oocytes and HEK cells
have produced data indicating that subunit composition directly
affects the desensitization properties of GABA-A receptors
(Martinez-Torres et al., 2000; Bianchi and MacDonald, 2002;
Chang et al., 2002). In general, desensitization of GABA-A
plays an important role in regulating synaptic inhibition and
neurotransmitter release. However, the role it plays during
embryonic neurogenesis, a period when FMRP is critical, is less
clear. Owens et al. found that early cortical neurons display
less desensitization than more mature neurons, and that GABA-
A receptors are activated in a paracrine mechanism which
does not involve synaptic activation (Owens et al., 1999).
These results suggest that GABA plays extra-synaptic roles
during neuronal maturation that are not yet fully understood
More importantly, the role FMRP could play in the kinetics
of GABA-A desensitization has not been established yet. Our
study provides the first evidence for an FMRP-dependent
maturation of GABA responses in human neurons developing
in-vitro.
Abnormal Expression of Specific GABA-A
Subunits in FX Human Neurons
The functional analysis of GABA response in WT and FX in-
vitro human neurons led us to conclude that subunits in the
GABA-A receptor could be abnormally expressed in FX neurons.
We found that the α1 subunit was not expressed in WT nor
in FX neurons. Furthermore, there was no significant difference
between WT and FX neurons in the expression of γ 2s and δ
subunits. However, a significant increase in α2 expression and a
robust reduction in the expression of β2 subunit were found in
FX neurons as compared to WT, which could potentially explain
the immature phenotype observed in FX neurons. A similar
response to GABA, showing desensitization and lack of reactivity
to bicuculline (similar to “type 2”) was shown by Maddox et al.
in normal human dorsal root ganglion cells (DRGs) from adult
samples, but not in embryonic counterparts (Maddox et al.,
2004). In that study, and ours, a correlation between neuronal
immaturity and reduced expression of the GABA-Aβ2 subunit
was observed. It is important to note that both studies, Maddox
et al. and the current report, analyzed mRNA levels of GABA-A
subunits, rather than protein levels. Therefore, any conclusion on
the molecular conformation of the actual receptor could be made
only under the assumption that changes in transcription directly
reflect changes in translation, which might not be necessarily so.
Taken together, these data suggest that FMRP plays an important
role in the regulation of the development of the GABAergic
system in early human neurons.
In rodents, an increase in α2 expression has been linked
with immature GABA responses characterized by slow decay in
developing postnatal thalamic neurons (Okada et al., 2000). After
maturation however, higher expression of α1, lower expression of
α2 and faster decay are observed in the same neurons, indicating
that α2 is probably responsible for slower decay. The same
slow decay has been reported in-vitro in HEK cells following
overexpression of α2, resulting in a ∼10-fold slower decay for
α2 over α1 (Dixon et al., 2014). In contrast, two different studies
concluded that the slow decay component in GABA responses
is a result of α3 expression (Geracitano et al., 2012; Labrakakis
et al., 2014). Here we suggest that, in accordance to previous
studies, the increase in α2 expression in FX neurons, which
were predominantly “type-2,” could be responsible for the slower
decay in GABA responses in these neurons. A hypothesis can be
formulated by which FMRP plays a role in the downregulation
of α2 subunit during neuronal maturation. In FXS, where
FMRP expression is lost, α2 remains abnormally high, impairing
maturation. However, in order to test this hypothesis, more
experiments need to be conducted.
SUMMARY
The findings of the present study have never been reported
in the developing brain of the fmr1−/− mouse, and highlight
the potential significance of the FX-hESCs system in modeling
FXS. However, more studies are necessary to further explore the
role of FMRP in the GABAergic developmental switch and its
contribution to the pathology of FXS.
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